These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31955999)

  • 21. D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent.
    Beazely MA; Tong A; Wei WL; Van Tol H; Sidhu B; MacDonald JF
    J Neurochem; 2006 Sep; 98(5):1657-63. PubMed ID: 16879713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation.
    Szumlinski KK; Szechtman H
    Neuroreport; 2002 Apr; 13(5):563-6. PubMed ID: 11973446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum.
    Strömberg I; Popoli P; Müller CE; Ferré S; Fuxe K
    Eur J Neurosci; 2000 Nov; 12(11):4033-7. PubMed ID: 11069599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhou LW; Zhang SP; Weiss B
    Neurochem Int; 1996 Dec; 29(6):583-95. PubMed ID: 9113126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats.
    Sumaya IC; Byers DM; Irwin LN; Del Val S; Moss DE
    Pharmacol Biochem Behav; 2004 Aug; 78(4):727-33. PubMed ID: 15301928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visuomotor deficiency in panx1a knockout zebrafish is linked to dopaminergic signaling.
    Safarian N; Whyte-Fagundes P; Zoidl C; Grigull J; Zoidl G
    Sci Rep; 2020 Jun; 10(1):9538. PubMed ID: 32533080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
    Ma GF; Raivio N; Sabrià J; Ortiz J
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D2 receptor-mediated miRNA-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with Neuregulin-1 expression in mice.
    Wang P; Cao T; Chen J; Jiang Y; Wang C; Waddington JL; Zhen X
    Neuropharmacology; 2019 Oct; 157():107675. PubMed ID: 31233824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activating dopamine D2 receptors reduces brown adipose tissue thermogenesis induced by psychological stress and by activation of the lateral habenula.
    Brizuela M; Antipov A; Blessing WW; Ootsuka Y
    Sci Rep; 2019 Dec; 9(1):19512. PubMed ID: 31862967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D2 receptor activator quinpirole protects against trypsinogen activation during acute pancreatitis via upregulating HSP70.
    Ye X; Han X; Li B; Dai J; Wu Z; He Y; Wen L; Hu G
    Am J Physiol Gastrointest Liver Physiol; 2020 Jun; 318(6):G1000-G1012. PubMed ID: 32308041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
    Prabhu VV; Madhukar NS; Gilvary C; Kline CLB; Oster S; El-Deiry WS; Elemento O; Doherty F; VanEngelenburg A; Durrant J; Tarapore RS; Deacon S; Charter N; Jung J; Park DM; Gilbert MR; Rusert J; Wechsler-Reya R; Arrillaga-Romany I; Batchelor TT; Wen PY; Oster W; Allen JE
    Clin Cancer Res; 2019 Apr; 25(7):2305-2313. PubMed ID: 30559168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of D2-like dopaminergic receptors in the median eminence during the establishment of long-day inhibition of LH secretion in the ewe.
    Bertrand F; Thiery J; Picard S; Malpaux B
    J Endocrinol; 1999 Nov; 163(2):243-54. PubMed ID: 10556774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine and Stress System Modulation of Sex Differences in Decision Making.
    Georgiou P; Zanos P; Bhat S; Tracy JK; Merchenthaler IJ; McCarthy MM; Gould TD
    Neuropsychopharmacology; 2018 Jan; 43(2):313-324. PubMed ID: 28741626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B
    Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.